Innate Pharma (IPHA) Sof foyda bo'yicha sotuv rentabelligi

Innate Pharma S.A. (IPHA) tovar belgisi

Hamkorlik to'lovlaridan kelib chiqadigan daromadlar tebranishi savdo marjalariga ta'sir qiladi, bunda -1121.60 qiymati metrika darajasini ifodalaydi. Innate Pharma S.A. (IPHA) kompaniyasining biznes asosi ANKET platformasi va kompaniyani farmatsevtika sanoati gigantlari bilan bog'laydigan patentlarga tayanadi. Testlarni samarali autsorsing qilish va intellektual mulkka to'liq nazorat qilish vendor risklarini minimallashtirib, aktivning strategik barqarorligini ta'minlaydi.

IPHA: Innate Pharma S.A Kompaniyaning sof rentabelligi 04.07.2022 - 19.11.2026

Innate Pharma S.A. kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:innate-pharma.com - IPHA
Innate Pharma, S.A. yetakchi tovari

Sotuv marjasi jami tushumda sof foydaning ulushini o'lchaydi va bu operatsion daromadni yakuniy aksiyadorlar kapitaliga aylantirish samaradorligini baholash imkonini beradi. Asosiy operatsiyalarning sof marjini tahlil qilish aktivlarning haddan tashqari yuqori baholanganligini aniqlashga yordam beradi, bu esa daromadliligi onkologiya sohasidagi texnologik gigantlar bilan strategik ittifoqlar doirasidagi R&D moliyalashtirish hajmi bilan bevosita bog'liq bo'lgan Innate Pharma S.A. (IPHA) uchun juda muhimdir.

Raqobatchilar tahlili

NantKwest (IBRX) - Sof marja|Sof marja Immunocore PLC (IMCR)|Sof foyda bo'yicha sotuv rentabelligi JANX|RCUS - Sof foyda bo'yicha marjinallik|Sof foyda bo'yicha sotuv rentabelligi ZYME (Zymeworks Corp)|Kompaniyaning sof rentabelligi TNGX|Sotuvning sof marjinal rentabelligi IOVA (Iovance Biotherapeutics, Inc.)|Sof foyda normasi IMTX|xencor.com - Sotuvning sof marjinal rentabelligi|Sof marja Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Sof marja|Lyell Immunopharma - Sof foyda normasi|PYXS (Pyxis) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi cgen.com|Sof marja IO Biotech (IOBT)|STRO: Sof foyda marjasi|MiNK Therapeutics Inc. - Sof foyda bo'yicha sotuv rentabelligi|werewolftx.com (HOWL) - Sof marja|Immix Biopharma Inc. - Sotuvning sof marjinal rentabelligi|ALXO - Sotuvning sof marjinal rentabelligi|CUE: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi PDSB|Sof marja Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi LIMN|Sotuvning sof marjinal rentabelligi Lava Tx (LVTX)|Sotuvning sof marjinal rentabelligi NXTC (NextCure Corporation)|Sof foyda normasi LPTX|INTS - Sof marja|Kompaniya sotuv marjasi Sensei Biotherapeutics Inc SNSE|TOVX: Sotuvning sof marjinal rentabelligi|Sof marja Gritstone Bio (GRTS)|KA (Kineta Corp) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi NEXI (NexImmune Corp)|Sotuvning sof marjinal rentabelligi TSBX|VCNX (Vaccinex, Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi HARP (Harpoon Therapeutics, Inc.)